{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T01:08:37Z","timestamp":1776301717404,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["humanpathol.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.humpath.2017.10.007","type":"journal-article","created":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T18:16:15Z","timestamp":1508868975000},"page":"84-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["General paucity of genomic alteration and low tumor mutation burden in refractory and metastatic hepatoblastoma: comprehensive genomic profiling study"],"prefix":"10.1016","volume":"70","author":[{"given":"Hwajeong","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony","family":"El Jabbour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanaz","family":"Ainechi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurie M.","family":"Gay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia A.","family":"Elvin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo-Anne","family":"Vergilio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Suh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shakti H.","family":"Ramkissoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siraj M.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexa","family":"Schrock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Fabrizio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garrett","family":"Frampton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tipu","family":"Nazeer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent A.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip J.","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey S.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2017.10.007_bb0005","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1053\/j.semdp.2016.12.015","article-title":"Hepatoblastoma","volume":"34","author":"Sharma","year":"2017","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.humpath.2017.10.007_bb0010","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S1470-2045(16)30598-8","article-title":"Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic Tumors International Collaboration","volume":"18","author":"Meyers","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.humpath.2017.10.007_bb0015","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/gcc.22390","article-title":"Small cell undifferentiated (SCUD) hepatoblastomas: All malignant rhabdoid tumors?","volume":"55","author":"Vokuhl","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2017.10.007_bb0020","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/hep.28888","article-title":"Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups","volume":"65","author":"Sumazin","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.humpath.2017.10.007_bb0025","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3727\/105221616X693639","article-title":"Novel advances in understanding of molecular pathogenesis of hepatoblastoma: a Wnt\/\u03b2-catenin perspective","volume":"17","author":"Bell","year":"2017","journal-title":"Gene Expr"},{"key":"10.1016\/j.humpath.2017.10.007_bb0030","doi-asserted-by":"crossref","first-page":"44","DOI":"10.21037\/tgh.2016.04.01","article-title":"Pediatric liver transplantation for hepatoblastoma","volume":"1","author":"Trobaugh-lotrario","year":"2016","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10.1016\/j.humpath.2017.10.007_bb0035","first-page":"293","article-title":"Pediatric hepatoblastoma: diagnosis and treatment","volume":"3","author":"Hiyama","year":"2014","journal-title":"Transl Pediatr"},{"key":"10.1016\/j.humpath.2017.10.007_bb0040","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.jpedsurg.2011.11.073","article-title":"Changing treatment and outcome of children with hepatoblastoma: analysis of a single center experience over the last 20 years","volume":"47","author":"Ismail","year":"2012","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.humpath.2017.10.007_bb0045","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jhep.2014.08.009","article-title":"The genomic landscape of hepatoblastoma and their progenies with HCC-like features","volume":"61","author":"Eichenm\u00fcller","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.humpath.2017.10.007_bb0050","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/PAS.0b013e3181ce5f1e","article-title":"Effects of neoadjuvant chemotherapy on hepatoblastoma: a morphologic and immunohistochemical study","volume":"34","author":"Wang","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2017.10.007_bb0055","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.ejca.2012.10.003","article-title":"Relapses in hepatoblastoma patients: clinical characteristics and outcome \u2013 experience of the International Childhood Liver Tumour Strategy Group (SIOPEL)","volume":"49","author":"Semeraro","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.humpath.2017.10.007_bb0060","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejca.2015.09.023","article-title":"The Children's Hepatic Tumors International Collaboration (CHIC): novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model","volume":"52","author":"Czauderna","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.humpath.2017.10.007_bb0065","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nbt.2696","article-title":"Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing","volume":"31","author":"Frampton","year":"2013","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.humpath.2017.10.007_bb0070","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/cncr.10282","article-title":"Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group","volume":"94","author":"Schnater","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2017.10.007_bb0075","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jpedsurg.2015.10.053","article-title":"Relapsed hepatoblastoma confined to the lung is effectively treated with pulmonary metastasectomy","volume":"51","author":"Shi","year":"2016","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.humpath.2017.10.007_bb0080","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.21873\/anticanres.11143","article-title":"Therapeutic innovations for targeting hepatoblastoma","volume":"36","author":"Garnier","year":"2016","journal-title":"Anticancer Res"},{"key":"10.1016\/j.humpath.2017.10.007_bb0085","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00383-012-3237-9","article-title":"Pharmacological inhibition of beta-catenin in hepatoblastoma cells","volume":"29","author":"Ellerkamp","year":"2013","journal-title":"Pediatr Surg Int"},{"key":"10.1016\/j.humpath.2017.10.007_bb0090","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1245\/s10434-016-5132-4","article-title":"Correlation of CTNNB1 mutation status with progression arrest rate in RECIST progressive desmoid-type fibromatosis treated with imatinib: translational research results from a phase 2 study of the German Interdisciplinary Sarcoma Group (GISG-01)","volume":"23","author":"Kasper","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.humpath.2017.10.007_bb0095","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jhep.2014.10.021","article-title":"Complete response of Ctnnb1-mutated tumour to \u03b2-catenin suppression by locked nucleic acid antisense in a mouse hepatocarcinogenesis model","volume":"62","author":"Delgado","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.humpath.2017.10.007_bb0100","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1002\/ijc.24810","article-title":"Small molecule antagonists of Tcf4\/beta-catenin complex inhibit the growth of HCC cells in vitro and in vivo","volume":"126","author":"Wei","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2017.10.007_bb0105","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1002\/jcb.25903","article-title":"Therapeutic potential of targeting Wnt\/\u03b2-catenin pathway in treatment of colorectal cancer: rationale and progress","volume":"118","author":"Bahrami","year":"2017","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.humpath.2017.10.007_bb0110","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1399-3046.2011.01515.x","article-title":"The use of everolimus in pediatric liver transplant recipients: first experience in a single center","volume":"15","author":"Nielsen","year":"2011","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.humpath.2017.10.007_bb0115","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jhep.2010.01.025","article-title":"Personalized molecular targeted therapy in advanced, recurrent hepatocellular carcinoma after liver transplantation: a proof of principle","volume":"52","author":"Bhoori","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.humpath.2017.10.007_bb0120","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.freeradbiomed.2014.11.003","article-title":"Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity-implications for therapeutic targeting of Nrf2","volume":"78","author":"Olayanju","year":"2015","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.humpath.2017.10.007_bb0125","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/modpathol.2013.80","article-title":"Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium","volume":"27","author":"L\u00f3pez-Terrada","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2017.10.007_bb0130","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.bbrc.2016.01.045","article-title":"Development of an ErbB4 monoclonal antibody that blocks neuregulin-1-induced ErbB4 activation in cancer cells","volume":"470","author":"Okazaki","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.humpath.2017.10.007_bb0135","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.biopha.2017.03.073","article-title":"FAM83D knockdown regulates proliferation, migration and invasion of colorectal cancer through inhibiting FBXW7\/Notch-1 signalling pathway","volume":"90","author":"Mu","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.humpath.2017.10.007_bb0140","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.4155\/fmc-2017-0067","article-title":"Aminoisoquinoline benzamides, FLT3 and Src-family kinase inhibitors, potently inhibit proliferation of acute myeloid leukemia cell lines","volume":"9","author":"Larocque","year":"2017","journal-title":"Future Med Chem"},{"key":"10.1016\/j.humpath.2017.10.007_bb0145","doi-asserted-by":"crossref","first-page":"12425","DOI":"10.1038\/ncomms12425","article-title":"Synthetic viability by BRCA2 and PARP1\/ARTD1 deficiencies","volume":"7","author":"Ding","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.humpath.2017.10.007_bb0150","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1158\/1078-0432.CCR-16-1829","article-title":"Checkpoint proteins in pediatric brain and extracranial solid tumors: opportunities for immunotherapy","volume":"23","author":"Ring","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2017.10.007_bb0155","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1177\/1756283X17698090","article-title":"The potential role of comprehensive genomic profiling to guide targeted therapy for patients with biliary cancer","volume":"10","author":"Lee","year":"2017","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.humpath.2017.10.007_bb0160","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/pbc.26018","article-title":"Low frequency of programmed death ligand 1 expression in pediatric cancers","volume":"63","author":"Aoki","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.humpath.2017.10.007_bb0165","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/jgh.13165","article-title":"Pure fetal histology subtype was associated with better prognosis of children with hepatoblastoma: A Chinese population-based study","volume":"31","author":"Qiao","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.humpath.2017.10.007_bb0170","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/pbc.21834","article-title":"Small cell undifferentiated variant of hepatoblastoma: adverse clinical and molecular features similar to rhabdoid tumors","volume":"52","author":"Trobaugh-lotrario","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.humpath.2017.10.007_bb0175","doi-asserted-by":"crossref","first-page":"e320","DOI":"10.1097\/MPH.0b013e3182580471","article-title":"Relationship of \u03b2-catenin and postchemotherapy histopathologic changes with overall survival in patients with hepatoblastoma","volume":"34","author":"Gupta","year":"2012","journal-title":"J Pediatr Hematol Oncol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817717303763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817717303763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T00:25:25Z","timestamp":1719534325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817717303763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":35,"alternative-id":["S0046817717303763"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2017.10.007","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"General paucity of genomic alteration and low tumor mutation burden in refractory and metastatic hepatoblastoma: comprehensive genomic profiling study","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2017.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}